Evidence map›Paper›PMID 27183599›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

IL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function.

Amina Abdul Qayum, Anuya Paranjape, Daniel Abebayehu, Elizabeth Motunrayo Kolawole, Tamara T Haque, Jamie Josephine Avila McLeod, Andrew J Spence, Heather L Caslin, Marcela T Taruselli, Alena P Chumanevich and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. A Critical Role for NaJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Amina Abdul QayumDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Anuya ParanjapeDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Daniel AbebayehuDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.ORCID 0000-0002-6837-3028
Elizabeth Motunrayo KolawoleDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Tamara T HaqueDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Jamie Josephine Avila McLeodDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Andrew J SpenceDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Heather L CaslinDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Marcela T TaruselliDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Alena P ChumanevichDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC 29208.
Bianca BakerDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and.
Carole A OskeritzianDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC 29208.ORCID 0000-0003-1380-9186
John J RyanDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284; and jjryan@vcu.edu.
Virginia Commonwealth University · USUniversity of South Carolina · US

Funding

Virginia Commonwealth University IRADCAK12GM093857 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI DANIEL C BULLARD, John J Ryan · 2010 to 2026
$7.0M
Virginia Commonwealth University Initiative for Maximizing Student DevelopmentR25GM090084 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI AKBARALI, HAMID I, LLOYD, JOYCE A. · 2010 to 2022
$5.2M
IL-10 Regulates Mast Cell Function and SurvivalR01AI059638 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI RYAN, JOHN J · 2007 to 2017
$3.8M
Control of IgG-mediated Inflammation by Fyn and Lyn KinasesR01AI101153 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI RYAN, JOHN J · 2013 to 2017
$2.0M
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammationR01AI095494 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI OSKERITZIAN, CAROLE A · 2012 to 2015
$1.4M
NIAID NIH HHS R01 AI059638NIAID NIH HHS R01 AI095494NIAID NIH HHS R01 AI101153NIGMS NIH HHS K12 GM093857NIGMS NIH HHS R25 GM090084
6 · The paper itself

Abstract

IL-10 is an important regulatory cytokine that modulates a wide range of immune cells. Whereas it is best known for its ability to suppress immune responses, IL-10 has been found to be pathogenic in several human and animal studies of immune-mediated diseases. There is a considerable gap in our understanding of the molecular mechanisms behind the stimulatory effects of IL-10 during allergic inflammation. IL-10 treatment has been shown to suppress mast cell TNF production. In this study, we report that whereas TNF secretion was reduced, IL-10 surprisingly enhanced IgE-mediated protease and cytokine production both in vitro and in vivo. This stimulatory effect was consistent in mouse and human skin mast cells. IL-10 enhanced activation of the key FcεRI signaling proteins Stat5, JNK, and ERK. We demonstrate that IL-10 effects are dependent on Stat3 activation, eliciting miR-155 expression, with a resulting loss of suppressor of cytokine signaling-1. The importance of miR-155 was demonstrated by the inability of IL-10 to enhance anaphylaxis in miR-155-deficient mice. Taken together, our results reveal an IL-10-induced, Stat3-miR-155 signaling pathway that can promote mast cell responses.

Indexed as

AnimalsCells, CulturedImmunoglobulin EInterleukin-10Mast CellsMiceMice, Inbred C57BLMice, KnockoutMicroRNAsSuppressor of Cytokine Signaling 1 ProteinImmunoglobulin EInterleukin-10MicroRNAsMirn155 microRNA, mouseSocs1 protein, mouseSuppressor of Cytokine Signaling 1 Protein

Identifiers

PMID27183599
PMCPMC4875869
OpenAlexW2342497022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.